Zanzalintinib Plus Pembrolizumab Versus Pembrolizumab Alone In Patients with PD-L1 Positive Metastatic Head And Neck Squamous Cell Carcinoma (STELLAR-305): A Double-Blind, Randomized, Placebo-Controlled, Phase 2/3 Study
- Resource Type
- Abstract
- Source
- In
International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e40-e41 - Subject
- Language
- ISSN
- 0360-3016